← SynDRA
BETAMETHASONE ACETATE
SynDRA canonical compound SYN0023046 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NR3C1 |
| Mechanism of action | glucocorticoid receptor agonist |
| Indication | corticosteroid-responsive dermatoses |
| Disease area | dermatology |
All known targets
- NR3C1
- ANXA1
- Nr3c1
- HRH1
- CHRM1
- CHRM3
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- NR3C1 AGONIST
- NR3C1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Glucocorticoids
- Hormones
- Anti-Asthmatic Agents
- Respiratory System Agents
- anti-inflammatory agent
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- D07X · CORTICOSTEROIDS, OTHER COMBINATIONS
- H02A · CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
- S02B · CORTICOSTEROIDS
- S01C · ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- S01B · ANTIINFLAMMATORY AGENTS
- A07E · INTESTINAL ANTIINFLAMMATORY AGENTS
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- C05A · AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
- CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
- CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
Cross-references
Synonyms
- BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
- CELESTONE SOLUSPAN
- Betamethasone 21-acetate
- NSC-759196
- Betamethasone acetate component of celestone soluspan
- Betamethasone acetate component of osurnia
- betamethasone-21-acetate
- TI05AO53L7
- NSC 759196
- CHEBI:31275
- OSURNIA COMPONENT BETAMETHASONE ACETATE
- RefChem:54523
- DTXCID402668
- MFCD00867462
- beta-Methasone acetate
- Betamethasone (acetate)
- Betamethasone acetate [JAN]
- UNII-TI05AO53L7
- Betamethasone 21
- Betamethasone acetate [USP:JAN]
- EINECS 213-578-6
- Betamethason-21-acetat
- Betamethasone acetate CRS
- SCHEMBL7592
- orb1705241
- orb3025859
- Betamethasone acetate (JAN/USP)
- MSK2253
- GLXC-23434
- BETAMETHASONE ACETATE [VANDF]
- HY-13570B
- MSK2253-100A
- BETAMETHASONE ACETATE [MART.]
- AKOS015896575
- BETAMETHASONE ACETATE [USP-RS]
- BETAMETHASONE ACETATE [WHO-DD]
- MSK2253-1000A
Reported adverse events
- Cardiac arrest
- Cushing's syndrome
- Hypersensitivity
- Skin atrophy
- Erythema
- Rash
- Acne
- Perioral dermatitis
- Pruritus
- Anaphylactoid reaction
- Arachnoiditis
- Bradycardia
Look up BETAMETHASONE ACETATE in the interactive SynDRA portal →